Understanding and managing airway diseases like asthma and COPD
Defining and Controlling Airway Disease
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11075128
This study is looking at how the cells lining your airways react to injuries and infections, with the goal of finding ways to help them heal better and improve conditions like asthma and COPD, so that patients can have healthier airways and new treatment options.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11075128 on ClinicalTrials.gov |
What this research studies
This research investigates the role of airway epithelial cells in responding to injury and infection, focusing on how these cells contribute to airway repair and the development of diseases such as asthma and COPD. By exploring the molecular mechanisms that govern normal and abnormal cell behavior, the research aims to identify how these cells can be reprogrammed to restore healthy airway function. Patients may benefit from insights into how infections can lead to chronic airway diseases and potential new therapeutic strategies for managing these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from asthma, COPD, or other airway diseases who are interested in new treatment options.
Not a fit: Patients with non-respiratory conditions or those without airway diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve airway health and reduce the impact of chronic diseases like asthma and COPD.
How similar studies have performed: Previous research has shown promising results in understanding airway epithelial cell behavior, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HOLTZMAN, MICHAEL J — WASHINGTON UNIVERSITY
- Study coordinator: HOLTZMAN, MICHAEL J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Airway Disease